Abstract
Summary
This study compared the effects sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture. By using national survey data, we suggest that the relationship between sarcopenia and metabolic syndrome or insulin resistance is potentiated by the severity of osteoarthritis and is independent of body weight.
Introduction
Sarcopenia and osteoarthritis are known risk factors for metabolic syndrome. However, their combined effects on metabolic syndrome, insulin resistance and osteoporosis remain uncertain.
Methods
We used data from the fifth Korean National Health and Nutrition Examination Survey using a total of 3158 adults (age >50 years). Sarcopenia was defined as a skeletal muscle index score (appendicular skeletal muscle mass/body weight) within the fifth percentile of sex-matched younger reference participants. Radiographic knee osteoarthritis was defined as a Kellgren-Lawrence (K-L) grade of 2 or greater. Metabolic syndrome was diagnosed using the National Cholesterol Education Program criteria. Insulin resistance was evaluated using the homeostasis model assessment-estimated insulin resistance index (HOMA-IR). Osteoporosis was defined using the World Health Organization T-score criteria.
Results
In multivariable logistic regression analysis, the sarcopenic osteoarthritis group had a higher odds ratio (OR) for metabolic syndrome (OR = 11.00, 95 % confidential interval (CI) = 2.12–56.99, p = 0.013) than the non-sarcopenic osteoarthritis (OR = 1.02, 95 % CI = 0.65–1.62, p = 0.972) and sarcopenic non-osteoarthritis groups (OR = 7.15, 95 % CI = 1.57–32.53, p = 0.027). Similarly, sarcopenic osteoarthritis had a greater OR of highest HOMA-IR quartiles (OR = 8.19, 95 % CI = 2.03–33.05, p = 0.003) than the other groups. Overall, the association between the K-L grade and body mass index was significant; however, this significance was lower in individuals with sarcopenia and was lost in those with sarcopenic osteoarthritis. Additionally, osteoporosis and bone fracture were not associated to sarcopenic osteoarthritis (p > 0.05).
Conclusions
These results suggest that the relationship between sarcopenia and metabolic syndrome or insulin resistance is potentiated by the severity of osteoarthritis and is independent of body weight.
Similar content being viewed by others
Abbreviations
- ANCOVA:
-
Analysis of covariance
- ASM:
-
Appendicular skeletal muscle mass
- BMI:
-
Body mass index
- BP:
-
Blood pressure
- BMD:
-
Bone mineral densitometry
- CI:
-
Confidential intervals
- HDL:
-
High-density lipoprotein
- HOMA-IR:
-
Homeostasis model assessment-estimated insulin resistance index.
- IL:
-
Interleukin
- K-L grade:
-
Kellgren-Lawrence grade
- KNHANES:
-
Korean National Health and Nutrition Examination Survey
- LDL:
-
Low-density lipoprotein
- MetS:
-
Metabolic syndrome
- NCEP-ATP:
-
National Cholesterol Education Program-Adult Treatment Panel
- OA:
-
Osteoarthritis
- OR:
-
Odds ratio
- SE:
-
Standard error
- SMI:
-
Skeletal muscle index
- SR:
-
Sarcopenia
- TNF:
-
Tumor necrosis factor
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–23
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–56
Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–9
Waters DL, Baumgartner RN (2011) Sarcopenia and obesity. Clin Geriatr Med 27(3):401–21
Kim TN, Park MS, Lim KI, Yang SJ, Yoo HJ, Kang HJ et al (2011) Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract 93(2):285–91
Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ et al (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33(7):1652–4
Lim KI, Yang SJ, Kim TN, Yoo HJ, Kang HJ, Song W et al (2010) The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS). Clin Endocrinol (Oxf) 73(5):588–94
Kim HG, Han J, Kim MH, Cho KH, Shin IH, Kim GH et al (2009) Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol 15(1):86–94
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131–5
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–7
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18(5):388–95
Cho HJ, Chang CB, Kim KW, Park JH, Yoo JH, Koh IJ et al (2011) Gender and prevalence of knee osteoarthritis types in elderly Koreans. J Arthroplasty 26(7):994–9
Park H, Lee SK (2011) Association of obesity with osteoarthritis in elderly Korean women. Maturitas 70(1):65–8
Chapple CM, Nicholson H, Baxter GD, Abbott JH (2011) Patient characteristics that predict progression of knee osteoarthritis: a systematic review of prognostic studies. Arthritis Care Res (Hoboken) 63(8):1115–25
Thijssen E, van Caam A, van der Kraan PM (2015) Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford) 54(4):588–600
Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA (1994) Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol 139(2):119–29
Sayer AA, Poole J, Cox V, Kuh D, Hardy R, Wadsworth M et al (2003) Weight from birth to 53 years: a longitudinal study of the influence on clinical hand osteoarthritis. Arthritis Rheum 48(4):1030–3
Sturmer T, Sun Y, Sauerland S, Zeissig I, Gunther KP, Puhl W et al (1998) Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol 25(9):1827–32
Davies-Tuck ML, Hanna F, Davis SR, Bell RJ, Davison SL, Wluka AE et al (2009) Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther 11(6):R181
Triantaphyllidou IE, Kalyvioti E, Karavia E, Lilis I, Kypreos KE, Papachristou DJ (2013) Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthr Cartil 21(2):322–30
Lippiello L, Walsh T, Fienhold M (1991) The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 40(6):571–6
Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T (2010) Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 28(8):1033–9
Pluijm SM, Visser M, Smit JH, Popp-Snijders C, Roos JC, Lips P (2001) Determinants of bone mineral density in older men and women: body composition as mediator. J Bone Min Res Off J Am Soc Bone Min Res 16:2142–2151
Taaffe DR, Cauley JA, Danielson M, Nevitt MC, Lang TF, Bauer DC, Harris TB (2001) Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J Bone Min Res Off J Am Soc Bone Min Res 16:1343–1352
Joo NS, Dawson-Hughes B, Yeum KJ (2013) 25-Hydroxyvitamin D, calcium intake, and bone mineral content in adolescents and young adults: analysis of the fourth and fifth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3, 2008–2009 and V-1, 2010). J Clin Endocrinol Metab 98(9):3627–36
Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J et al (1990) Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52(2):214–8
Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–96
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502
Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–52
Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ et al (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75(1):72–80
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–9
Roubenoff R (2000) Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 904:553–7
Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS ONE 5(5):e10805
Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W et al (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 33(8):885–92
Lee S, Kim TN, Kim SH (2012) Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum 64(12):3947–54
Haseeb A, Haqqi TM (2013) Immunopathogenesis of osteoarthritis. Clin Immunol 146(3):185–96
Loeser RF (2010) Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 26(3):371–86
Metcalfe D, Harte AL, Aletrari MO, Al Daghri NM, Al Disi D, Tripathi G et al (2012) Does endotoxaemia contribute to osteoarthritis in obese patients? Clin Sci 123(11):627–34
Papalia R, Zampogna B, Torre G, Lanotte A, Vasta S, Albo E et al (2014) Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence? Musculoskelet Surg 98(1):9–14
Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C (2013) Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis 72(4):535–40
Gomis A, Miralles A, Schmidt RF, Belmonte C (2007) Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application. Pain 130(1–2):126–36
Shin D (2014) Association between metabolic syndrome, radiographic knee osteoarthritis, and intensity of knee pain: results of a national survey. J Clin Endocrinol Metab 99(9):3177–83
Kim JH, Cho JJ, Park YS (2015) Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci 30(3):264–71
Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Min Res Off J Am Soc Bone Min Res 23:17–29
Roodman GD (1993) Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 53(Suppl 1):S94–98
Yoo HJ, Park MS, Yang SJ, Kim TN, Lim KI, Kang HJ, Song W, Baik SH, Choi DS, Choi KM (2012) The differential relationship between fat mass and bone mineral density by gender and menopausal status. J Bone Miner Metab 30:47–53
Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W et al (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33(7):1497–9
Authors’ contributions
Sang Mi Chung, Myung Han Hyun, Eunmi Lee, and Hong Seog Seo are responsible for the conception and design of the study. Sang Mi Chung, Eunmi Lee, and Myung Han Hyun are responsible for the the acquisition of data. Sang Mi Chung, Myung Han Hyun, Eunmi Lee, and Hong Seog Seo are responsible for the analysis and interpretation of data. Sang Mi Chung, Myung Han Hyun, Eunmi Lee, and Hong Seog Seo are responsible for the drafting of the manuscript. Sang Mi Chung, Myung Han Hyun, Eunmi Lee, and Hong Seog Seo are responsible for the critical revision of the manuscript for important intellectual content. Myung Han Hyun is responsible for the statistical analysis. Hong Seog Seo is responsible for the administrative support and study supervision. Sang Mi Chung, Myung Han Hyun, Eunmi Lee, and Hong Seog Seo are responsible for the final approval of manuscript.
Author access to data
Hong Seog Seo and Eunmi Lee had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None.
Source of funding and support
This work was supported by a grant from the Korea Institute of Science and Technology Institutional Program (Project No. 2E24080), a grant from the Korea University-Korea Institute of Science and Technology (KU-KIST) Graduate School of Converging Science and Technology (R1307921).
Additional information
S. M. Chung and M. H. Hyun contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
Study flow chart (DOCX 47 kb)
Rights and permissions
About this article
Cite this article
Chung, S.M., Hyun, M.H., Lee, E. et al. Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey. Osteoporos Int 27, 2447–2457 (2016). https://doi.org/10.1007/s00198-016-3548-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3548-0